Muhle, Hiltrud
Kurlemann, Gerhard
Lehmann, Irene
Hamer, Hajo
Mayer, Thomas
Potschka, Heidrun
Schubert-Bast, Susanne
Strzelczyk, Adam
Pringsheim, Milka
Funding for this research was provided by:
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Article History
Accepted: 15 November 2023
First Online: 3 January 2024
Declarations
:
: H. Muhle reports personal fees from Desitin Arzneimittel, UCB, Novartis, GW Pharmaceuticals companies and Zogenix. G. Kurlemann reports personal fees from Desitin Arzneimittel, Eisai, GW Pharmaceuticals companies, UCB, Novartis, Takeda, Neuraxpharm and Zogenix. H. Hamer has served on the scientific advisory board of Arvelle, Corlieve, Desitin, Eisai, GW, Sandoz, UCB Pharma and Zogenix and the speakers’ bureau of, or received unrestricted grants from, Amgen, Ad-Tech, Bracco, Desitin, Eisai, GW, Micromed, Nihon Kohden, Novartis, Pfizer and UCB Pharma. T. Mayer reports personal fees and grants from Arvelle Therapeutics, Eisai, GW Pharmaceuticals companies, UCB and Zogenix. H. Potschka reports personal fees and grants from Angelini, Eisai, Zogenix, Lario, Epidarex/Exceed, Roche, Jazz Pharmaceuticals, Galapagos, MSD, and collaborations with various pharmaceutical companies as partners of the EU-IMI EQIPD consortium (ExternalRef removed). S. Schubert-Bast reports personal fees from Eisai, Desitin Pharma, GW Pharmaceuticals companies, LivaNova, UCB and Zogenix. A. Strzelczyk received personal fees and grants from Angelini Pharma, Biocodex, Desitin Arzneimittel, Eisai, Jazz (GW) Pharmaceuticals, Marinus Pharma, Precisis, Takeda, UCB (Zogenix) Pharma, and UNEEG medical. AS is editor-in-chief of <i>Clinical Epileptology</i> and editorial board member of <i>Neurological Research and Practice</i>. M. Pringsheim reports personal fees from Zogenix. I. Lehmann declares that she has no competing interests.
: This article does not contain any studies with human participants or animals performed by any of the authors. We confirm that we have read the journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.